<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00347230</url>
  </required_header>
  <id_info>
    <org_study_id>R419/14/2005</org_study_id>
    <nct_id>NCT00347230</nct_id>
  </id_info>
  <brief_title>Intacs for Keratoconus</brief_title>
  <official_title>Intacs for Keratoconus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Singapore National Eye Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Singapore National Eye Centre</source>
  <brief_summary>
    <textblock>
      To study the effects Intacs intracorneal ring segments(Addition Technology, Inc) insertion in&#xD;
      the treatment of keratoconus&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this evaluation is to study the effects of implanting INTACS inserts,&#xD;
      identical to those commercially available to correct myopia, into the corneal stroma of&#xD;
      patients with keratoconus (mild to moderate) and having a clear cornea. The principle of the&#xD;
      procedure is to flatten the cornea deformed by keratoconus. One or two segments of the same&#xD;
      or a different thickness will be selected to reduce the asymmetric astigmatism responsible&#xD;
      for the patient impaired visual acuity.&#xD;
&#xD;
      The surgical technique is based on locating the INTACS inserts on the flattest axis of the&#xD;
      refractive error, making the incision on the steepest axis, using 150 degree arc length&#xD;
      inserts with different sizes (0.250, 0.300, 0.350, 0.400 &amp; 0.450 mm) according to a nomogram&#xD;
      designed for this technique using the INTACS Instrumentation (10-Step Prolate System&#xD;
      instruments).&#xD;
&#xD;
      The corneal lamellar channel creation may be performed using the INTACS instrumentation or&#xD;
      using the Femtosecond laser (Femtec 20/10 laser[Femtec,Heidelberg Germany])&#xD;
&#xD;
      Primary Assessment Criteria&#xD;
&#xD;
        -  Evaluation of the safety of the device for the treatment of patients with keratoconus&#xD;
           (mild to moderate)&#xD;
&#xD;
        -  Maintenance of best corrected visual acuity (BCVA)&#xD;
&#xD;
        -  Improvement in uncorrected visual acuity (UCVA)&#xD;
&#xD;
        -  Reduction in manifest refraction spherical equivalent&#xD;
&#xD;
        -  Reduction in asymmetric astigmatism&#xD;
&#xD;
      Secondary Assessment Criteria&#xD;
&#xD;
        -  Evaluation of the effect of INTACS inserts placement for treatment of corneal ectasia&#xD;
&#xD;
        -  Determination of patient satisfaction following the INTACS inserts procedure Patients&#xD;
           meeting the eligibility criteria are required to sign a Patient Informed Consent Form&#xD;
           prior to study participation.&#xD;
&#xD;
      A thorough examination is perform to evaluate the following:&#xD;
&#xD;
        -  Manifest refraction results - Uncorrected visual acuity (UCVA) and best corrected visual&#xD;
           acuity (BCVA)&#xD;
&#xD;
        -  Cycloplegic refraction results - Uncorrected visual acuity (UCVA) and best corrected&#xD;
           visual acuity (BCVA)&#xD;
&#xD;
        -  Corneal topography&#xD;
&#xD;
        -  Pachymetry&#xD;
&#xD;
        -  Step axis location&#xD;
&#xD;
        -  Location of incision placement&#xD;
&#xD;
        -  Subjective feedback about quality of vision (Excellent, Good, Fair and Poor)&#xD;
&#xD;
      Post-operative Assessment(at 1 day, 1 week, 1 month and 3 months postop)&#xD;
&#xD;
        -  Uncorrected visual acuity (UCVA) and best corrected visual acuity with manifest&#xD;
           refraction(BCVA) at designated time interval&#xD;
&#xD;
        -  Cycloplegic refraction results - Uncorrected visual acuity (UCVA) and best corrected&#xD;
           visual acuity (BCVA) at designated time interval&#xD;
&#xD;
        -  Corneal topography at designated time interval&#xD;
&#xD;
        -  Pachymetry at designated time interval&#xD;
&#xD;
        -  Subjective visual outcome ratings over time (Excellent, Good, Fair and Poor)&#xD;
&#xD;
        -  Report adverse events&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2005</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Refraction</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal topography</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction following procedure</measure>
  </secondary_outcome>
  <enrollment>20</enrollment>
  <condition>Keratoconus</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intacs intracorneal ring insertion for the treatment of keratoconus</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients must have keratoconus (mild to moderate).&#xD;
&#xD;
          -  Visual acuity with contact lenses must be better than or equal to (20/40).&#xD;
&#xD;
          -  Patients must be intolerant of contact lenses, i.e., they must be unable to wear&#xD;
             contact lenses for a whole day.&#xD;
&#xD;
          -  Patients will have a corneal thickness of 425 microns at the site of ICRS (INTACS&#xD;
             inserts) placement (the thinnest region of the cornea).&#xD;
&#xD;
          -  In terms of general health, patients must not have any illnesses posing an immediate&#xD;
             threat to life.&#xD;
&#xD;
          -  Patients must have provided written informed consent at least one week prior to&#xD;
             surgery.&#xD;
&#xD;
          -  Patients must over 21 years of age.&#xD;
&#xD;
          -  Patients' contact lenses must have been removed at least one week prior to surgery for&#xD;
             soft lenses and two weeks prior to surgery for hard lenses.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Positive pregnancy test.&#xD;
&#xD;
          -  Breast-feeding.&#xD;
&#xD;
          -  History of previous ophthalmologic surgery on the operative eye.&#xD;
&#xD;
          -  Patients with corneal stromal disorders.&#xD;
&#xD;
          -  Patients with history of herpetic keratitis.&#xD;
&#xD;
          -  Patients with retinal disorders.&#xD;
&#xD;
          -  Corneal grafts.&#xD;
&#xD;
          -  Patients refusing to remove contact lenses one week before surgery for soft lenses and&#xD;
             two weeks before surgery for hard lenses.&#xD;
&#xD;
          -  Patients with amblyopia (VA &lt;1110 for the contralateral eye).&#xD;
&#xD;
          -  Patients with corneal thickness &lt;425 microns.&#xD;
&#xD;
          -  Patients with TOP &lt;10 mmHg or &gt;21 mmHg.&#xD;
&#xD;
          -  Patients taking part in other biomedical research in the 30 days prior to the start of&#xD;
             this study.&#xD;
&#xD;
          -  Patients with an uncooperative disposition.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald TH Tan, FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Singapore National Eye Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Li - Lim, FRCS(Ed)</last_name>
    <phone>65-63228896</phone>
    <email>Lim.Li@snec.com.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Donald TH Tan, FRCS</last_name>
    <phone>65-63224500</phone>
    <email>snecdt@pacific.net.sg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Singapore National Eye Centre</name>
      <address>
        <city>Singapore</city>
        <zip>168751</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Li - Lim, FRCS(Ed)</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <reference>
    <citation>Colin J, Cochener B, Savary G, Malet F, Holmes-Higgin D. INTACS inserts for treating keratoconus: one-year results. Ophthalmology. 2001 Aug;108(8):1409-14.</citation>
    <PMID>11470691</PMID>
  </reference>
  <reference>
    <citation>Colin J, Cochener B, Savary G, Malet F. Correcting keratoconus with intracorneal rings. J Cataract Refract Surg. 2000 Aug;26(8):1117-22.</citation>
    <PMID>11008037</PMID>
  </reference>
  <reference>
    <citation>Siganos D, Ferrara P, Chatzinikolas K, Bessis N, Papastergiou G. Ferrara intrastromal corneal rings for the correction of keratoconus. J Cataract Refract Surg. 2002 Nov;28(11):1947-51.</citation>
    <PMID>12457667</PMID>
  </reference>
  <reference>
    <citation>Schanzlin DJ, Asbell PA, Burris TE, Durrie DS. The intrastromal corneal ring segments. Phase II results for the correction of myopia. Ophthalmology. 1997 Jul;104(7):1067-78.</citation>
    <PMID>9224455</PMID>
  </reference>
  <reference>
    <citation>Siganos CS, Kymionis GD, Kartakis N, Theodorakis MA, Astyrakakis N, Pallikaris IG. Management of keratoconus with Intacs. Am J Ophthalmol. 2003 Jan;135(1):64-70.</citation>
    <PMID>12504699</PMID>
  </reference>
  <verification_date>September 2005</verification_date>
  <study_first_submitted>June 30, 2006</study_first_submitted>
  <study_first_submitted_qc>June 30, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2006</study_first_posted>
  <last_update_submitted>July 3, 2006</last_update_submitted>
  <last_update_submitted_qc>July 3, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2006</last_update_posted>
  <keyword>Intacs ring segments</keyword>
  <keyword>Keratoconus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

